Cns & Neurological Disorders-drug Targets

Journal Title：Cns & Neurological Disorders-drug Targets

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

目標和范圍

《中樞神經系統和神經系統疾病 - 藥物靶點》旨在涵蓋神經系統和中樞神經系統 (CNS) 疾病所涉及的當代分子靶點的藥物化學、藥理學、分子生物學、基因組學和生物化學方面的所有最新和杰出進展，例如疾病特異性蛋白質、受體、酶、基因。

《中樞神經系統和神經系統疾病 - 藥物靶點》出版由該領域領導者撰寫的客座編輯專題，涵蓋一系列當前中樞神經系統和神經系統藥物靶點的主題。該期刊還接受發表原創研究文章、信件、評論和藥物臨床試驗研究。

隨著用于神經系統和中樞神經系統藥物發現的新型人類藥物靶點的發現、鑒定、表征和驗證不斷增長；這本期刊是所有參與藥物發現和開發的制藥科學家的必讀讀物。

Cns & Neurological Disorders-drug Targets創刊于2006年，由Bentham Science Publishers B.V.出版商出版，收稿方向涵蓋醫學 - 神經科學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 較慢,6-12周 ，影響因子指數2.7，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。